Biofrontera Analyst Ratings
Benchmark Co. Maintains Biofrontera(BFRI.US) With Buy Rating, Maintains Target Price $7
Benchmark Co. Reaffirms Their Buy Rating on Biofrontera (BFRI)
Analysts' Top Healthcare Picks: Biofrontera (BFRI), Alpine Immune Sciences (ALPN)
Benchmark Reiterates Buy on Biofrontera, Maintains $18 Price Target
Biofrontera Analyst Ratings
Benchmark Adjusts Biofrontera's Price Target to $18 From $140, Keeps Buy Rating
Benchmark Maintains Buy on Biofrontera, Lowers Price Target to $18
Analysts Offer Insights on Healthcare Companies: Outset Medical (OM), Biofrontera (BFRI) and 2seventy Bio (TSVT)
Benchmark Reiterates Buy on Biofrontera, Maintains $7 Price Target
Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), Jasper Therapeutics (JSPR) and Biofrontera (BFRI)
Benchmark Adjusts Price Target on Biofrontera to $7 From $11, Reiterates Buy Rating
Benchmark Reiterates Buy on Biofrontera, Lowers Price Target to $7
Biofrontera Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Biofrontera (BFRI)
No Data
No Data